people emotions optimist suicide experts

Experts Weigh in on Esketamine's Approval for People With Suicidal Thoughts

Reading now: 472
themighty.com

In 2019, Janssen Pharmaceuticals’ esketamine (brand name Spravato), a “chemical cousin” to ketamine, became the first new medication approved to treat clinical depression in three decades.

Meant for “treatment-resistant” depression, you take the drug nasal spray in a doctor’s office — meaning esketamine can’t be taken at home — along with your regular antidepressant.

Now, the Food and Drug Administration (FDA) approved a supplemental application to use esketamine with patients who have suicidal thoughts.

Read more on themighty.com
The website mental.guide is an aggregator of articles from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the article if you find it unreliable.

Related articles

DMCA